GGrantIndex
← Leaderboards

Farouc Amin Jaffer

Massachusetts General Hospital

$9,945,391
Attributed
$13,248,750
Total exposure
7
Grants
5
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.6M · FY201025
$2M$1.5M$1M$500K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$13,248,750 · 7

By mechanism

R01$12,724,072 · 5
R41$524,678 · 2

Top collaborators

Most similar at Massachusetts General Hospital

Same institution · by research overlap

Others in their field

Top investigators on “Catheters

Research focus

CathetersInflammationImageLaboratoriesIn VivoStentsStructureOryctolagus CuniculusArterial Fatty StreakFluorescenceMyocardial InfarctionCoronary ArteryCoronaryInflammatoryAtherosclerosisUltrasonographyMolecular ImagingDoseMolecularPharmaceutical PreparationsDesignEngineeringCoronary ArteriosclerosisPeptide Hydrolases

Grant awards (24)

Clinical translation of targeted intracoronary imaging for inflammatory activity$740,316
R01 · FY2025 · HL
Clinical translation of targeted intracoronary imaging for inflammatory activity$712,744
R01 · FY2024 · HL
Clinical translation of targeted intracoronary imaging for inflammatory activity$771,347
R01 · FY2023 · HL
Intravascular NIRF-IVUS imaging of inflammation-guided arterial therapy$498,138
R01 · FY2023 · HL · contact PI
Clinical translation of targeted intracoronary imaging for inflammatory activity$767,728
R01 · FY2022 · HL
Intravascular NIRF-IVUS imaging of inflammation-guided arterial therapy$498,138
R01 · FY2022 · HL · contact PI
Intravascular NIRF-IVUS imaging of inflammation-guided arterial therapy$542,549
R01 · FY2021 · HL · contact PI
Preventing Post-Thrombotic Syndrome after Deep Vein Thrombosis with Perivascular Anti-Inflammatory Agent Delivery$299,678
R41 · FY2021 · HL
Novel PET/CT and Treatment Strategies to reduce PTS following DVT$823,128
R01 · FY2020 · HL · contact PI
Intravascular NIRF-IVUS imaging of inflammation-guided arterial therapy$710,328
R01 · FY2020 · HL · contact PI
Novel PET/CT and Treatment Strategies to reduce PTS following DVT$820,597
R01 · FY2019 · HL · contact PI
Novel PET/CT and Treatment Strategies to reduce PTS following DVT$826,096
R01 · FY2018 · HL · contact PI
NIRF-OFDI of Inflammation in Atheroma Progression and Stent Complications$566,491
R01 · FY2018 · HL · contact PI
Intravascular molecular-structural NIRF-IVUS imaging of coronary artery disease$225,000
R41 · FY2018 · HL · contact PI
Novel PET/CT and Treatment Strategies to reduce PTS following DVT$845,084
R01 · FY2017 · HL · contact PI
NIRF-OFDI of Inflammation in Atheroma Progression and Stent Complications$568,899
R01 · FY2017 · HL · contact PI
NIRF-OFDI of Inflammation in Atheroma Progression and Stent Complications$450,032
R01 · FY2016 · HL · contact PI
NIRF-OFDI of Inflammation in Atheroma Progression and Stent Complications$35,269
R01 · FY2016 · HL · contact PI
NIRF-OFDI of Inflammation in Atheroma Progression and Stent Complications$451,190
R01 · FY2015 · HL · contact PI
Intravascular Fluorescence Molecular Imaging of Inflammation in Atherosclerosis$423,108
R01 · FY2014 · HL · contact PI
Intravascular Fluorescence Molecular Imaging of Inflammation in Atherosclerosis$411,063
R01 · FY2013 · HL · contact PI
Intravascular Fluorescence Molecular Imaging of Inflammation in Atherosclerosis$431,848
R01 · FY2012 · HL · contact PI
Intravascular Fluorescence Molecular Imaging of Inflammation in Atherosclerosis$436,521
R01 · FY2011 · HL · contact PI
Intravascular Fluorescence Molecular Imaging of Inflammation in Atherosclerosis$393,458
R01 · FY2010 · HL · contact PI